Self-Funding Drug Trials (with Public Good Pharma)
“I realize there's this massive disconnect in the business model whereby you've got governments and health insurers paying billions and billions of dollars for what might be a not very effective therapy, and then there's all these potential cures, even, and much better treatments out there.” - Savva Kerdemelidis Savva Kerdemelidis and Zan Lowe, of Public Good Pharma, joined me this week to talk about re-aligning the incentive structures for drug development. In our current system, drugs are often funded based on how much of their formula is patentable, and manufacturers will tweak the…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.